Stimwave Technologies requests that their press release NewsItemId: 20190918005973 issued September 18, 2019 “Stimwave Launches Post-Market Peripheral Neuropathy Pain Relief Randomized Controlled Trial for Pain Awareness Month” be killed.
The release was transmitted with an incorrect boilerplate for Stimwave by Stimwave Technologies.
A replacement release will not be issued.
Contacts:
